These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 20133630)
1. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Berger T; Cheung CC; Elia AJ; Mak TW Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630 [TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Leng X; Ding T; Lin H; Wang Y; Hu L; Hu J; Feig B; Zhang W; Pusztai L; Symmans WF; Wu Y; Arlinghaus RB Cancer Res; 2009 Nov; 69(22):8579-84. PubMed ID: 19887608 [TBL] [Abstract][Full Text] [Related]
4. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis. Zuo Y; Ulu A; Chang JT; Frost JA Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144 [TBL] [Abstract][Full Text] [Related]
5. No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer. Cramer EP; Glenthøj A; Häger M; Juncker-Jensen A; Engelholm LH; Santoni-Rugiu E; Lund LR; Laerum OD; Cowland JB; Borregaard N PLoS One; 2012; 7(6):e39646. PubMed ID: 22737251 [TBL] [Abstract][Full Text] [Related]
6. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice. Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma. Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874 [TBL] [Abstract][Full Text] [Related]
8. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413 [TBL] [Abstract][Full Text] [Related]
11. Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer. Hallett MA; Teng B; Hasegawa H; Schwab LP; Seagroves TN; Pourmotabbed T Breast Cancer Res; 2013 Feb; 15(1):R12. PubMed ID: 23407024 [TBL] [Abstract][Full Text] [Related]
12. Lipocalin 2 promotes lung metastasis of murine breast cancer cells. Shi H; Gu Y; Yang J; Xu L; Mi W; Yu W J Exp Clin Cancer Res; 2008 Dec; 27(1):83. PubMed ID: 19077278 [TBL] [Abstract][Full Text] [Related]
13. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862 [TBL] [Abstract][Full Text] [Related]
15. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model. Almholt K; Juncker-Jensen A; Laerum OD; Danø K; Johnsen M; Lund LR; Rømer J Mol Cancer Ther; 2008 Sep; 7(9):2758-67. PubMed ID: 18790756 [TBL] [Abstract][Full Text] [Related]
16. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434 [TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cho SG; Wang Y; Rodriguez M; Tan K; Zhang W; Luo J; Li D; Liu M Cancer Res; 2011 Oct; 71(20):6535-46. PubMed ID: 21852382 [TBL] [Abstract][Full Text] [Related]
18. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model. Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590 [TBL] [Abstract][Full Text] [Related]
19. Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice. He L; Zhu Z; Chen S; Wang Y; Gu H Cancer Med; 2016 Jun; 5(6):1292-7. PubMed ID: 26992445 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer. Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]